Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Mar;40(3):351-359.
doi: 10.1007/s00270-016-1513-0. Epub 2016 Dec 5.

Peripheral Stent Thrombosis Leading to Acute Limb Ischemia and Major Amputation: Incidence and Risk Factors in the Aortoiliac and Femoropopliteal Arteries

Affiliations

Peripheral Stent Thrombosis Leading to Acute Limb Ischemia and Major Amputation: Incidence and Risk Factors in the Aortoiliac and Femoropopliteal Arteries

Konstantinos Katsanos et al. Cardiovasc Intervent Radiol. 2017 Mar.

Abstract

Purpose: To report the real-world incidence and risk factors of stent thrombosis in the aortoiliac and femoropopliteal arteries in case of bare nitinol stent (BNS) or covered nitinol stent (CNS) placement from a single-centre retrospective audit.

Materials and methods: Medical records of consecutive patients treated with peripheral stent placement for claudication or critical limb ischemia were audited for definite stent thrombosis defined as imaging confirmed stent thrombosis that presented as acute limb-threatening ischemia. Cases were stratified between aortoiliac and femoropopliteal anatomy. Cox regression analysis was employed to adjust for baseline clinical and procedural confounders and identify predictors of stent thrombosis and major limb loss.

Results: 256 patients (n = 277 limbs) were analysed over a 5-year period (2009-2014) including 117 aortoiliac stents (34 CNS; 12.8 ± 5.0 cm and 83 BNS; 7.8 ± 4.0 cm) and 160 femoropopliteal ones (60 CNS; 21.1 ± 11.0 cm and 100 BNS; 17.5 ± 11.9 cm). Median follow-up was 1 year. Overall stent thrombosis rate was 6.1% (17/277) after a median of 43 days (range 2-192 days) and affected almost exclusively the femoropopliteal segment (12/60 in the CNS cohort vs. 4/100 in the BNS; p = 0.001). Annualized stent thrombosis rates (per 100 person-years) were 12.5% in case of CNS and 1.4% in case of BNS (HR 6.3, 95% CI 2.4-17.9; p = 0.0002). Corresponding major amputations rates were 8.7 and 2.5%, respectively (HR 4.5, 95% CI 2.7-27.9; p = 0.0006). On multivariable analysis, critical leg ischemia and CNS placement were the only predictors of stent thrombosis. Diabetes, critical leg ischemia, femoropopliteal anatomy, long stents and CNS were independent predictors of major amputations.

Conclusions: Placement of long femoropopliteal covered nitinol stents is associated with an increased incidence of acute stent thrombosis and ensuing major amputation. Risks are significantly lower in the aortoiliac vessels and with use of bare nitinol stents.

Keywords: Acute limb ischemia; Covered stent; Major amputation; Nitinol stent; Stent thrombosis.

PubMed Disclaimer

Conflict of interest statement

On behalf of all authors, the corresponding author states that there is no conflict of interest. Ethical approval This was a retrospective clinical audit. For this type of study, formal consent is not required.

Figures

Fig. 1
Fig. 1
Time-to-event analysis with the Kaplan–Meier method of events of stent thrombosis in case of aortoiliac arteries stratified according to the stent type used (covered and bare nitinol stent cohorts)
Fig. 2
Fig. 2
Time-to-event analysis with the Kaplan–Meier method of events of stent thrombosis in case of femoropopliteal arteries stratified according to the stent type used (covered and bare nitinol stent cohorts)
Fig. 3
Fig. 3
Time-to-event analysis with the Kaplan–Meier method of major lower limb amputations in case of aortoiliac arteries stratified according to the stent type used (covered and bare nitinol stent cohorts)
Fig. 4
Fig. 4
Time-to-event analysis with the Kaplan–Meier method of major lower limb amputations in case of femoropopliteal arteries stratified according to the stent type used (covered and bare nitinol stent cohorts)

References

    1. Fowkes FG, Rudan D, Rudan I, et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet. 2013;382(9901):1329–1340. doi: 10.1016/S0140-6736(13)61249-0. - DOI - PubMed
    1. Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA Guidelines for the Management of Patients with Peripheral Arterial Disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Associations for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (writing committee to develop guidelines for the management of patients with peripheral arterial disease)–summary of recommendations. J Vasc Interv Radiol. 2006;17(9):1383–1397. doi: 10.1097/01.RVI.0000240426.53079.46. - DOI - PubMed
    1. Moysidis T, Opdenplatz D, Kulendik V, et al. Percutaneous endovascular treatment of peripheral arterial disease in Germany. Cardiovasc Revasc Med. 2015;16(5):290–293. doi: 10.1016/j.carrev.2015.05.003. - DOI - PubMed
    1. White CJ, Gray WA. Endovascular therapies for peripheral arterial disease: an evidence-based review. Circulation. 2007;116(19):2203–2215. doi: 10.1161/CIRCULATIONAHA.106.621391. - DOI - PubMed
    1. Pastromas G, Katsanos K, Krokidis M, Karnabatidis D, Spiliopoulos S. Emerging stent and balloon technologies in the femoropopliteal arteries. Sci World J. 2014;2014:695402. doi: 10.1155/2014/695402. - DOI - PMC - PubMed

MeSH terms

LinkOut - more resources